GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (MIL:1ILMN) » Definitions » Other Income (Expense)

Illumina (MIL:1ILMN) Other Income (Expense) : €-799 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Illumina Other Income (Expense)?

Illumina's other income expense for the Illumina's pretax income for the three months ended in Mar. 2024 was €7 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-799 Mil.

Illumina Other Income (Expense) Historical Data

The historical data trend for Illumina's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Other Income (Expense) Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.00 233.45 945.18 -4,413.20 -803.29

Illumina Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.27 -10.15 -788.95 -7.34 7.36

Illumina Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-799 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina  (MIL:1ILMN) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Illumina (MIL:1ILMN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (MIL:1ILMN) » Definitions » Other Income (Expense)
Comparable Companies
WAT LH DGX ICLR RVTY MTD MEDP CRL NTRA EXAS TMO DHR IQV XSWX:LONN IDXX A SHSE:603259 XPAR:BIM XPAR:ERF QGEN
Traded in Other Exchanges
ILMN:USA ILMN:Mexico ILU:Germany ILMN:Austria
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Website
https://www.illumina.com
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (MIL:1ILMN) Headlines

No Headlines